"Sravan has a proven track record of maximizing shareholder value through his extensive involvement in numerous mergers, acquisitions, and corporate financing transactions in the healthcare industry," said Peter Arduini, president and chief executive officer, Integra LifeSciences. "His healthcare experience, financial acumen and market perspective will be invaluable to Integra as we continue to implement our growth strategies, manage our capital structure efficiently, and meet the company's liquidity needs."
Most recently, Emany was a managing director in the Mergers & Acquisitions group at Bank of America Merrill Lynch. While at Bank of America Merrill Lynch, he led numerous mergers and acquisitions in the healthcare sector, including the recent Integra acquisitions of Codman Neurosurgery and Derma Sciences. Prior to this role, he assumed positions of increasing responsibility in mergers and acquisitions and investment banking at other firms, including Goldman Sachs and Morgan Stanley.
Mr. Emany holds a B.A. in international relations and an M.A. in international relations and international economics from The Johns Hopkins University.